BFRI News and Press, Biofrontera Inc. From 02/05/24

FDA has set a target action date of October 4, 2024 sNDA supported by two Phase 1 safety studies 1 Aims at actinic keratosis (AK) field treatment with up to 3 tubes An estimated 13 million treatments given each year for AK in the US 2 WOBURN, MA / ACCESSWIRE / February 5, 2024 /...

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 5.0% to $11.72 on volume of 189,765,259 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.8% to $5.09 on volume of 143,664,257 shares Amazon.com Inc. (AMZN) rose 7.9% to $171.81 on volume of ...

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 5.5% to $11.665 on volume of 166,461,596 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.1% to $5.075 on volume of 129,958,072 shares Remark Holdings Inc. (MARK) rose 16.2% to $0.593899 on ...

2024-02-02 12:31:34 ET More on Mid-day movers & stocks. CalAmp Corp. (CAMP) Q3 2024 Earnings Call Transcript Kopin: Visionary Leadership Fuels Growth And Market Potential Kopin Corporation (KOPN) Q3 2023 Earnings Call Transcript CalAmp GAAP EPS of -$2.27 ...

2024-02-02 09:52:50 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...

2024-02-02 08:21:14 ET More on pre-market losers & stocks etc. Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript New ADHD drugs could pay off for pharmaceutical companies Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alphaȁ...

2024-02-02 07:34:39 ET DENVER, Colo., Feb. 2, 2024 ( www.247marketnews.com )- Biofrontera Inc. ( NASDAQ:BFRI ) is gaining steam, in this morning’s premarket trading. TransCode Therapeutics is trading at $1.61, up $0.275 (+20.60%), on 361.5K shares traded. Its 52-week ...

2024-01-17 08:34:00 ET More on Biofrontera Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Biofrontera For further details see: Biofrontera files to sell common stock, warrants

2024-01-11 16:32:10 ET More on Biofrontera Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofrontera Financial information for Biofrontera For further details s...

WOBURN, MA / ACCESSWIRE / January 11, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced preliminary, unaudited revenues for the three and twelve months ended December 31, 2023. Biofrontera achie...